CETSABLE
LIVE

Serial Number

79335884

Owner

Pelago Bioscience AB

Attorney

Sandra J. Lex

Filing Date

Oct 18, 2021

Add to watchlist:

No watchlists yet
View on USPTO

CETSABLE Trademark

Serial Number: 79335884 • Registration: 7123403

CETSABLE is a trademark filed by Pelago Bioscience AB on October 18, 2021. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

Pelago Bioscience AB (4 trademarks)

Nobels Väg 3
65 Solna SE171 , SE

Entity Type: 16

Trademark Details

Filing Date

October 18, 2021

Registration Date

August 1, 2023

Published for Opposition

May 16, 2023

Goods & Services

biochemicals for in vitro and in vivo scientific use; diagnostic preparations for scientific or research use; in-vivo diagnostic reagents for scientific use; tagged antibodies for scientific use; polymers for use in the analysis of proteins; reagents for scientific purposes; testing reagents for scientific use; universal reagents for automated test systems for laboratory use; universal reagents for automated test systems for scientific use; chemical substances for scientific use; enzymes for scientific purposes; enzymes for scientific and research purposes in detecting proteins; proteins for scientific and research purposes in detecting antibodies; proteins for use in science; protein in raw material form for scientific and research purposes; chemical substances for impregnation into membranes to separate proteins from liquids; enzymes for scientific and research purposes for measuring proteins; chemical substances for analysis in laboratories, other than for medical or veterinary purposes

Services of a chemical and/or biological laboratory; research and development services in the field of chemistry; laboratory analysis in the field of chemistry; scientific laboratory services; biological laboratory services; testing of pharmaceuticals; analysis of human tissues for medical research; research on the subject of pharmaceuticals; research and development of vaccines and medicines; conducting early evaluations in the field of new pharmaceuticals; medical research; biological research; medical laboratory services; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; pharmaceutical drug development services; scientific research and development; biochemical research and development; biochemical analysis; biochemistry research services; biological analysis; biomedical research services; chemical research and analysis services

Enzymes for medical purposes; diagnostic biomarker reagents for medical purposes; diagnostic chemical reagents for medical use; diagnostic preparations for medical or veterinary purposes; diagnostic reagents for medical use; chemical reagents for medical or veterinary purposes; chemical test reagents for medical purposes; chemical test reagents for veterinary purposes; reagents for analytical purposes for medical purposes; reagents for use in analysis for medical purposes; reagents for in-vitro laboratory use for medical purposes; reagents and media for medical and veterinary diagnostic purposes

Filing History

NEW REPRESENTATIVE AT IB RECEIVED
Nov 21, 2025 NREP
FINAL DECISION TRANSACTION PROCESSED BY IB
Nov 27, 2023 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Nov 2, 2023 FICS
FINAL DISPOSITION PROCESSED
Nov 1, 2023 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Nov 1, 2023 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Aug 1, 2023 NRCC
REGISTERED-PRINCIPAL REGISTER
Aug 1, 2023 R.PR
ASSIGNED TO EXAMINER
Jul 6, 2023 DOCK
NOTIFICATION PROCESSED BY IB
May 17, 2023 GPNX
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 16, 2023 NPUB
PUBLISHED FOR OPPOSITION
May 16, 2023 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Apr 26, 2023 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Apr 26, 2023 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 26, 2023 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 7, 2023 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 22, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 21, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 21, 2023 TROA
ATTORNEY REVIEW COMPLETED
Jan 9, 2023 ATRV
LIMITATION FROM THE IB - REQUEST EXAM REVIEW
Oct 7, 2022 LIME
REFUSAL PROCESSED BY IB
Sep 12, 2022 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Aug 22, 2022 RFCS
REFUSAL PROCESSED BY MPU
Aug 22, 2022 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jul 28, 2022 RFCR
NON-FINAL ACTION WRITTEN
Jul 27, 2022 CNRT
ASSIGNED TO EXAMINER
Jul 25, 2022 DOCK
NEW REPRESENTATIVE AT IB RECEIVED
Jun 19, 2022 NREP
LIMITATION OF GOODS RECEIVED FROM IB
May 29, 2022 LIMG
APPLICATION FILING RECEIPT MAILED
Mar 22, 2022 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 18, 2022 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Mar 17, 2022 REPR